Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H21Cl2NO5 |
InChIKeyOVULNOOPECCZRG-UHFFFAOYSA-N |
CAS Registry146726-73-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | Japan | - |





